INCREASED AMOUNTS OF A HIGH-MOLECULAR-WEIGHT INSULIN-LIKE GROWTH-FACTOR-II (IGF-II) PEPTIDE AND IGF-II MESSENGER-RIBONUCLEIC-ACID IN PANCREATIC-ISLETS OF DIABETIC GOTO-KAKIZAKI RATS
A. Hoog et al., INCREASED AMOUNTS OF A HIGH-MOLECULAR-WEIGHT INSULIN-LIKE GROWTH-FACTOR-II (IGF-II) PEPTIDE AND IGF-II MESSENGER-RIBONUCLEIC-ACID IN PANCREATIC-ISLETS OF DIABETIC GOTO-KAKIZAKI RATS, Endocrinology, 137(6), 1996, pp. 2415-2423
Insulin-like growth factor II (IGF-II), a member of the insulin family
, regulates cell growth and differentiation. The IGF-II gene is locali
zed close to the insulin gene in man and rat. IGF-II peptide binds wea
kly to the insulin receptor and exerts insulin-like effects on the blo
od glucose level. We studied IGF-II in endocrine pancreas in an animal
model of noninsulin-dependent diabetes mellitus, the Goto-Kakizaki (G
K) rat. At the age of 2 months, these rats have structural islet chang
es, with fibrosis and irregular configuration, so-called starfish-shap
ed islets. Immunohistochemical investigation revealed IGF-II immunorea
ctivity in the beta-cells in both GK and control rats. Pancreatic extr
action, followed by size separation using gel chromatography, disclose
d a high mol wt form of IGF-II in all animals, and RIA measurements re
vealed a considerably larger amount of the IGF-II peptide in the 2- an
d 6-month-old GK rats than in the 1-month GK and control rats. IN situ
hybridization of 3-month-old GK rats showed increased IGF-II messenge
r RNA expression in the starfish-shaped islets of GK rats than in the
islets with normal structure in both diabetic and control animals. The
reason for the increased amount of IGF-II is unclear. As the animals
are diabetic before the islet changes occur, it might be a compensator
y effect in response to hyperglycemia, but could also be a cause of th
e islet fibrosis.